Copy Number Profiles of Prostate Cancer in Men of Middle Eastern Ancestry.

Our knowledge of prostate cancer (PCa) genomics mainly reflects European (EUR) and Asian (ASN) populations. Our understanding of the influence of Middle Eastern (ME) and African (AFR) ancestry on the mutational profiles of prostate cancer is limited. To characterize genomic differences between ME, EUR, ASN, and AFR ancestry, fluorescent in situ hybridization (FISH) studies for deletion and MYC amplification were carried out on 42 tumors arising in individuals of ME ancestry. These were supplemented by analysis of genome-wide copy number profiles of 401 tumors of all ancestries. FISH results of and were assessed in the ME cohort and compared to other ancestries. Gene level copy number aberrations (CNAs) for each sample were statistically compared between ancestry groups. -1 deletions by FISH were observed in 17/42 (17.5%) prostate tumors arising in men of ME ancestry, while amplifications were only observed in 1/42 (2.3%). Using CNAs called from arrays, the incidence of deletions was significantly lower in ME vs. other ancestries (20% vs. 52%; = 2.3 × 10). Across the genome, tumors arising in men of ME ancestry had fewer CNAs than those in men of other ancestries ( = 0.014). Additionally, the somatic amplification of 21 specific genes was more frequent in tumors arising in men of ME vs. EUR ancestry (two-sided proportion test; Q < 0.05). Those included amplifications in the glutathione S-transferase family on chromosome 1 (, , ) and the IQ motif-containing family on chromosome 3 (, , , , , ). Larger studies investigating ME populations are warranted to confirm these observations.